Investing.com - Heart Test Laboratories Unt reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Heart Test Laboratories Unt announced earnings per share of $-0.19 on revenue of $3.20K. Analysts polled by Investing.com anticipated EPS of $-0.18 on revenue of $0.00.
Heart Test Laboratories Unt shares are down 0% from the beginning of the year and are trading at $1.36 , down-from-52-week-high.
Heart Test Laboratories Unt follows other major Healthcare sector earnings this month
Heart Test Laboratories Unt's report follows an earnings beat by Medtronic on Tuesday, August 23, 2022, who reported EPS of $1.13 on revenue of $7.37B, compared to forecasts EPS of $1.12 on revenue of $7.22B.
Merck ADR had beat expectations on Friday, September 9, 2022 with third quarter EPS of $0.5392 on revenue of $5.69B, compared to forecast for EPS of $0.5165 on revenue of $5.57B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar